XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women

Background: XRCC1 (X-ray repair cross-complementing group 1) plays a central role in the DNA base excision repair mechanism. Single nucleotide polymorphisms (SNPs) in the XRCC1 gene are thought to modulate DNA repair capacity and have been linked to cancer risk in several studies. Materials and methods: We conducted a case-control study comprising 217 cervical samples, including 103 cervical carcinomas and 114 normal tissue samples. Cervical samples were genotyped for two XRCC1 SNPs (Arg194Trp and Arg399Gln) by PCR-RFLPs. Results: Subjects carrying heterozygous Arg399Gln or the combined Gln399Gln + Arg399Gln variant genotypes had a significantly reduced risk for cervical cancer development. In addition, the 194Arg-399Gln haplotype was also found to be associated with a decreased risk for cervical carcinoma. Conclusion: Our findings suggest that XRCC1 genotypes and haplotypes contribute in reducing the risk for cervical cancer development. Furthermore, genetic susceptibility conferred by Arg399Gln polymorphism operates independently of human papillomavirus infection of cervical tissue.

Cervical Cancer; HPV; Single Nucleotide Polymorphisms; XRCC1

[1] Global Cancer Statistics. A Cancer Journal for Clinicians. 2005, 55, 74.

[2] Matos E., Loria D., Amestoy G.M. et al.: “Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study”. Sex. Transm. Dis., 2003, 30, 593.

[3] Arrossi S., Ramos S., Paolino M., Sankaranarayanan R.: “Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina”. Reprod. Health Matters, 2008, 16, 50.

[4] IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papillomaviruses, Lyon, International Agency For Research On Cancer, 2006.

[5] Goode E.L., Ulrich C.M., Potter J.D.: “Polymorphisms in DNA repair genes and associations with cancer risk”. Cancer Epidemiol. Biomark. Prev., 2002, 11, 1513.

[6] Taylor R.M., Thistlethwaite A., Caldecott K.W.: “Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair”. Mol. Cell. Biol., 2002, 22, 2556.

[7] Hu Z., Ma H., Chen F., Wei Q., Shen H.: “XRCC1 Polymorphisms and cancer risk: a meta-analysis of 38 case-control studies”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1810.

[8] Shen M., Jones I.M., Mohrenweiser H.: “Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans”. Cancer Res., 1998, 58, 604.

[9] Huang J., Ye F., Chen H., Lu W., Xie X.: “The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and highrisk human papillomavirus infection”. Int. J. Gynecol. Cancer, 2007, 17, 668.

[10] He X., Ye F., Zhang J., Cheng Q., Shen J., Chen H.: “REV1 genetic variants associated with the risk of cervical Carcinoma”. Eur. J. Epidemiol., 2008, 23, 403.

[11] Shu X., Cai Q., Gao Y., Wen W., Jin F., Zheng W.: “A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer”. Cancer Epidemiol. Biomarkers Prev., 2003, 12, 1462.

[12] Li H., Ha T.C., Tai B.C.: “XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysis”. Breast, 2009, 18, 183.

[13] Kiyohara C., Takayama K., Nakanishi Y.: “Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: A meta-analysis”. Lung Cancer, 2006, 54, 267.

[14] Schneider J., Classen V., Helmig S.: “XRCC1 polymorphism and lung cancer risk”. Expert Rev. Mol. Diagn., 2008, 8, 761.

[15] Lao T., Gu W., Huang Q.: “A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk”. Mutagenesis, 2008, 6, 523.

[16] Figl A., Scherer D., Nagore E., Bermejo J.L., Botella-Estrada R., Gast A. et al.: “Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients”. Mutat. Res., 2009, 661, 78.

[17] Hu Z., Ma H., Chen F., Wei Q., Shen H.: “XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1810.

[18] Geng J., Zhang Y.W., Huang G.C., Chen L.B.: “XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis”. World J. Gastroenterol., 2008, 14, 6733.

[19] Hiyama T., Yoshihara M., Tanaka S., Chayama K.: “Genetic polymorphisms and head and neck cancer risk (review)”. Int. J. Oncology, 2008, 32, 945.

[20] Thompson L.H., West M.G.: “XRCC1 keeps DNA from getting stranded”. Mutat. Res., 2000, 459, 1.

[21] Qu T., Morii E., Oboki K., Lu Y., Morimoto K.: “Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1”. Cancer Lett., 2005, 221, 91.

[22] Klein G.: “Toward a genetics of cancer resistance”. Proc. Natl. Acad. Sci. USA, 2009, 106, 859.

[23] Miller S.A., Dikes D.D., Polesky H.F.: “A simple salting out procedure for extracting DNA from human nucleated cells”. Nucleic Acid Res., 1988, 16, 1215.

[24] Ting Y., Manos M.M.: “Detection and typing of genital human Papillomavirus”. In: Innis M.A., Gelfand D.H., Sninsky J.J., White T.J. (eds.). PCR Protocols. San Diego: Academic Press., 1990, 356.

[25] Evander M., Edlund K., Boden E., Gustafsson A., Jonsson M., Karlsson R. et al.: “Comparison of a one-step and two-step polimerase chain reaction with degenerate general primers in a population-based study of human Papillomavirus infection in young Swedish women”. J. Clin. Microbiol., 1992, 30, 987.

[26] Li Y., Long C., Lin G., Marion M.J., Freyer G., Santella R.M. et al.: “Effect of the XRCC1 codon 399 polymorphism on the repair of vinyl chloride metabolite-induced DNA damage”. J. Carcinogenesis, 2009, 8, 14.

[27] Divine K.K., Gilliland F.D., Crowell R.E., Stidley C.A., Bocklage T.J., Cook D.L., Belinsky S.A.: “The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung”. Mutat Res., 2001, 461, 273.

[28] Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L. et al.: “Polymorphisms of the DNA repair gene XRCC1 and risk of gastric carcinoma in a Chinese population”. Int. J. Cancer, 2000, 88, 601.

[29] Sturgis E.M., Castillo E.J., Li L., Zheng R., Eicher S.A., Clayman G.L. et al.: “Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck”. Carcinogenesis, 1999, 20, 2125.

[30] Stern M.C., Umbach D.M., van Gils C.H., Lunn R.M., Taylor J.A.: “DNA repair gene XRCC1 polymorphisms, smoking, and bladder carcinoma risk”. Cancer Epidemiol Biomarkers Prev., 2001, 10, 125.

[31] Sobti R.C., Singh J., Kaur P., Pachouria S.S., Siddiquia E.A., Singh Bindrab H.: “XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population”. Cancer Genet. Cytogenet., 2007, 175, 91.

[32] Nelson H.H., Kelsey K.T., Mott L.A., Karagas M.R.: “The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction”. Cancer Res., 2002, 62, 152.

[33] Olshan A.F., Watson M.A., Weissler M.C. and Bell D.A.: “XRCC1 polymorphisms and head and neck cancer”. Cancer Lett., 2002, 178, 181.

[34] Niwa Y., Matsuo K., Ito H., Hirose K., Tajima K., Nakanishi T. et al.: “Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects”. Gynecol. Oncol., 2005, 99, 43.

[35] Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A.: “XRCC1 polymorphisms, effects on aflotoxin B1-DNA adducts and Glycophorin A variant frequency”. Cancer Res., 1999, 59, 2557.

[36] Abdel-Rahman S.Z., Soliman A.S., Bondy M.L., Omar S., El-Badawy S.A., Khaled H.M. et al.: “Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt”. Cancer Lett., 2000, 159, 79.

[37] Xing D., Qi J., Miao X., Lu W., Tan W., Lin D.: “Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population”. Int. J. Cancer, 2002, 100, 600.

[38] Andrew A.S., Nelson H.H., Kelsey K.T., Moore J.H., Meng A.C., Casella D.P. et al.: “Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility”. Carcinogenesis, 2006, 27, 1030.

[39] Ratnasinghe L.D., Abnet C., Qiao Y.L., Modalli R., Stolzenberg-Solomon R., Dong Z.W. et al.: “Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer”. Cancer Lett., 2004, 216, 157.

[40] Pérez L.O., Barbisan G., Abba M.C., Laguens R.M., Dulout F.N., Golijow C.D.: “Herpes simplex virus and human papillomavirus infection in cervical disease in Argentine women”. Int. J. Gynecol. Pathol., 2006, 25, 42.